Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 79726 - 79750 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Titanium dioxide	Approved	MUC4	4585	upregulated	titanium dioxide results in increased expression of MUC4 mRNA	3q29	A24434
Titanium dioxide	Approved	MYD88	4615	upregulated	titanium dioxide results in increased expression of MYD88 mRNA	3p22.2	A24217
Titanium dioxide	Approved	NFKB1	4790	downregulated	titanium dioxide results in decreased expression of NFKB1 mRNA	4q24	A24217
Titanium dioxide	Approved	NFKB2	4791	upregulated	titanium dioxide results in increased expression of NFKB2 mRNA	10q24.32	A24217
Titanium dioxide	Approved	NFKBIA	4792	downregulated	titanium dioxide results in decreased expression of NFKBIA mRNA	14q13.2	A24217
Titanium dioxide	Approved	NLRC4	58484	downregulated	titanium dioxide results in decreased expression of NLRC4 mRNA	2p22.3	A24217
Titanium dioxide	Approved	OPCML	4978	upregulated	titanium dioxide results in increased expression of OPCML mRNA	11q25	A24434
Titanium dioxide	Approved	PARP1	142	upregulated	titanium dioxide results in increased expression of PARP1 mRNA	1q42.12	A24436
Titanium dioxide	Approved	PCDH17	27253	upregulated	titanium dioxide results in increased expression of PCDH17 mRNA	13q21.1	A24434
Titanium dioxide	Approved	PCNA	5111	downregulated	[Vitallium analog binds to titanium dioxide] which results in decreased expression of PCNA mRNA	20p12.3	A24432
Titanium dioxide	Approved	PORCN	64840	upregulated	[Vitallium analog binds to titanium dioxide] which results in increased expression of PORCN mRNA	Xp11.23	A24432
Titanium dioxide	Approved	PRAM1	84106	upregulated	titanium dioxide results in increased expression of PRAM1 mRNA	19p13.2	A24434
Titanium dioxide	Approved	PSAP	5660	upregulated	[Vitallium analog binds to titanium dioxide] which results in increased expression of PSAP mRNA	10q22.1	A24432
Titanium dioxide	Approved	PTGS2	5743	downregulated	[Vitallium analog binds to titanium dioxide] which results in decreased expression of PTGS2 mRNA	1q31.1	A24432
Titanium dioxide	Approved	PTGS2	5743	upregulated	[Vitallium analog binds to titanium dioxide] which results in increased expression of PTGS2 mRNA	1q31.1	A24432
Titanium dioxide	Approved	RFC4	5984	downregulated	[Vitallium analog binds to titanium dioxide] which results in decreased expression of RFC4 mRNA	3q27.3	A24432
Titanium dioxide	Approved	SELE	6401	upregulated	titanium dioxide results in increased expression of SELE mRNA	1q24.2	A24442
Titanium dioxide	Approved	SERPINE1	5054	upregulated	titanium dioxide results in increased expression of SERPINE1 mRNA	7q22.1	A24217
Titanium dioxide	Approved	SIGLEC6	946	upregulated	titanium dioxide results in increased expression of SIGLEC6 mRNA	19q13.41	A24434
Titanium dioxide	Approved	SOD2	6648	upregulated	titanium dioxide results in increased expression of SOD2 mRNA	6q25.3	A24434 A24439
Titanium dioxide	Approved	SP7	121340	upregulated	titanium dioxide results in increased expression of SP7 mRNA	12q13.13	A20622
Titanium dioxide	Approved	STAB2	55576	upregulated	titanium dioxide results in increased expression of STAB2 mRNA	12q23.3	A24434
Titanium dioxide	Approved	TGFB1	7040	upregulated	titanium dioxide results in increased expression of TGFB1 mRNA	19q13.1	A24217
Titanium dioxide	Approved	TK1	7083	downregulated	[Vitallium analog binds to titanium dioxide] which results in decreased expression of TK1 mRNA	17q25.3	A24432
Titanium dioxide	Approved	TLR3	7098	upregulated	titanium dioxide results in increased expression of TLR3 mRNA	4q35.1	A24217

Displaying entries 79726 - 79750 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability